Our History
In 2005
Founded Natural Field Co., Ltd.
In 2012
Recognized as the national Industrial Demonstration Base for paclitaxel production.
In 2014
Passed BV certification and honored as an international Gold Supplier.
In 2018
Established Shanghai R&D Center.
In 2019
Completed shareholding reform and began capitalization process.
In 2021
Invested Xiamen Ginposome Pharmaceutical, which obtained API production license.
In 2023
Established Natural Field Inc. in the United States.
In 2024
Laboratory certified by CNAS and invested in Yunnan production base with Xiamen Ginposome.